Literature DB >> 6465373

Diagnosis and pharmacotherapy issues in the care of Hispanics in the public sector.

G L Adams, R J Dworkin, S D Rosenberg.   

Abstract

Clinical data from 1,752 ambulatory patients treated at five public mental health clinics were used to test hypotheses concerning the diagnoses and psychopharmacotherapy of Hispanic patients compared with Anglos and blacks. Hispanics were less likely than the other two groups to be labeled schizophrenic but more likely to be diagnosed as having other mental illnesses. Hispanics were less likely to receive medication than the other two groups. However, when pharmacotherapy was used there were no significant differences among groups in the number of medications prescribed. There were no differences among the groups in the doses prescribed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6465373     DOI: 10.1176/ajp.141.8.970

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Ethnic differences in the neuroleptic treatment of schizophrenia.

Authors:  P Ruiz; R V Varner; D R Small; B A Johnson
Journal:  Psychiatr Q       Date:  1999

2.  Managed care and academic psychiatry.

Authors:  H S Moffic; K Krieg; H Prosen
Journal:  J Ment Health Adm       Date:  1993

3.  Exploratory factor analysis of borderline personality disorder criteria in monolingual Hispanic outpatients with substance use disorders.

Authors:  Daniel F Becker; Luis Miguel Añez; Manuel Paris; Carlos M Grilo
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

Review 4.  Clinical trials and transethnic pharmacology.

Authors:  M E Kitler
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.